PCV60 - Estimating the Cost Per Percent Point Reduction in Ldl-C for Patients Treated with Pcsk9 Inhibitors in a Large National Health Plan.

Subjects

Subjects :

*CARDIOVASCULAR disease treatment
*ATHEROSCLEROSIS
*HEALTH planning
*THERAPEUTIC use of monoclonal antibodies
*LOW density lipoproteins
*MONTE Carlo method

Details

Language :

English

ISSN :

10983015

Volume :

19

Issue :

3

Database :

Academic Search Index

Journal :

Value in Health

Publication Type :

Academic Journal

Accession number :

115550449

Full Text :

https://doi.org/10.1016/j.jval.2016.03.125